Keyphrases
Cytokine Response
100%
Randomized Clinical Trial
100%
At Birth
100%
Vaccination
100%
Bacillus Calmette
100%
Cytokine Production
36%
Post-randomization
27%
Interleukin-22 (IL-22)
18%
Interleukin-6
9%
Interleukin-1β
9%
Interleukin-10
9%
Bleeding
9%
In Vitro Activation
9%
Candida Albicans (C. albicans)
9%
Escherichia Coli
9%
Interleukin-17 (IL-17)
9%
Streptococcus Pneumoniae
9%
Potentiating Effect
9%
Geometric Mean Concentration
9%
Vaccinated children
9%
IL-6/IL-10
9%
Medicine and Dentistry
Childbirth
100%
Randomized Clinical Trial
100%
In Vitro
100%
Cytokine Response
100%
Bacilli
100%
Cytokine Production
36%
Tumor Necrosis Factor
18%
Interleukin-6
18%
Pathogen
9%
Ciclonicate
9%
Escherichia coli
9%
Interleukin-1
9%
Streptococcus Pneumoniae
9%
Interleukin 17
9%
Phytohaemagglutinin
9%
Immunology and Microbiology
Cytokine Response
100%
Vaccination Policy
100%
Bacilli
100%
Cytokine Production
36%
Interleukin-6
18%
Tumor Necrosis Factor
18%
Infectious Agent
9%
Interleukin-1
9%
Candida Albicans
9%
Escherichia coli
9%
Interleukin 17
9%
Phytohaemagglutinin
9%
Streptococcus Pneumoniae
9%